Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patients Diagnosed With Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01451515
What this trial is testing

NHL16: Study For Newly Diagnosed Patients With Acute Lymphoblastic Lymphoma

Who this might be right for
Lymphoblastic Lymphoma
St. Jude Children's Research Hospital 23
Large-scale testing (Phase 3)WithdrawnNCT04849715
What this trial is testing

Parsaclisib, a PI3Kδ Inhibitor, in Combination With Bendamustine and Rituximab in Patients With Newly Diagnosed Mantle Cell Lymphoma

Who this might be right for
Mantle Cell Lymphoma
Incyte Corporation
Testing effectiveness (Phase 2)Study completedNCT00458978
What this trial is testing

Cediranib Maleate in Treating Patients With Recurrent or Newly Diagnosed Metastatic Head and Neck Cancer

Who this might be right for
Recurrent Hypopharyngeal Squamous Cell CarcinomaRecurrent Laryngeal Squamous Cell CarcinomaRecurrent Laryngeal Verrucous Carcinoma+20 more
National Cancer Institute (NCI) 6
Not applicableLooking for participantsNCT02978521
What this trial is testing

Pulmonary Rehabilitation in Advanced Non-small Cell Lung Cancer Patients

Who this might be right for
Pulmonary RehabilitationSarcopeniaQuality of Life
Instituto Nacional de Cancerologia de Mexico 94
Testing effectiveness (Phase 2)Study completedNCT01465347
What this trial is testing

Safety and Efficacy of Trans Sodium Crocetinate (TSC) With Radiation and Temozolomide in Newly Diagnosed Glioblastoma

Who this might be right for
GlioblastomaGBMGlioma
Diffusion Pharmaceuticals Inc 59
Testing effectiveness (Phase 2)Study completedNCT03394885
What this trial is testing

Atezolizumab With Neoadjuvant Chemotherapy for Patients With Newly-Diagnosed Advanced-Stage Ovarian Cancer

Who this might be right for
Ovarian CancerOvarian Neoplasms
Duke University 18
Large-scale testing (Phase 3)Study completedNCT00006343
What this trial is testing

STI571 Compared With Interferon Alfa Plus Cytarabine in Treating Patients With Newly Diagnosed Chronic Myelogenous Leukemia

Who this might be right for
Leukemia
Novartis
Testing effectiveness (Phase 2)UnknownNCT04876755
What this trial is testing

MBM-02 (Tempol) for the Treatment of Biochemical Recurrent Prostate Cancer

Who this might be right for
Prostate Cancer RecurrentBiochemical Recurrent Prostate Cancer
Matrix Biomed, Inc. 55
Testing effectiveness (Phase 2)Active Not RecruitingNCT06429098
What this trial is testing

Study of A Venetoclax-based, Anthracycline-free Regimen in Newly Diagnosed CBFβ::MYH11(+) AML

Who this might be right for
Acute Myeloid Leukemia
The First Affiliated Hospital of Soochow University 40
Not applicableUnknownNCT05161949
What this trial is testing

Artificial inTelligence in eNdometriosis-related ovArian Cancer and Precision Surgery in eNdometriosis-related ovArian Cancer

Who this might be right for
Patients With Suspected Ovarian CarcinomaNon Oncological Patients or With Endometriosis
IRCCS Azienda Ospedaliero-Universitaria di Bologna 240
Testing effectiveness (Phase 2)Study completedNCT00828009
What this trial is testing

BLP25 Liposome Vaccine and Bevacizumab After Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Stage IIIA or Stage IIIB Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery

Who this might be right for
Lung Cancer
ECOG-ACRIN Cancer Research Group 70
Not applicableActive Not RecruitingNCT07712016
What this trial is testing

Muco-active Agent Use and Clinical Outcomes After Lung Cancer Diagnosis in Chronic Obstructive Pulmonary Disease

Who this might be right for
Lung Cancer (Diagnosis)Chronic Obstructive Pulmonary Disease (COPD)
Seoul National University 27,000
Testing effectiveness (Phase 2)Study completedNCT00002964
What this trial is testing

Porfimer Sodium in Diagnosing Patients With Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
Roswell Park Cancer Institute
Not applicableUnknownNCT06109233
What this trial is testing

A Perspective Study of the MRD-tailored Therapy in Patients With Newly Diagnosed Multiple Myeloma With Persistent Minimal Residual Disease After Initial Treatment

Who this might be right for
Multiple MyelomaMinimal Residual Disease
FengYan Jin 80
Testing effectiveness (Phase 2)Study completedNCT00054158
What this trial is testing

Combination Chemotherapy and Thalidomide in Treating Patients With Stage I, Stage II, or Stage III Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Roswell Park Cancer Institute 24
Not applicableStudy completedNCT05763355
What this trial is testing

Multicentric Comparative Prospective Study of the Benefits and Risks of Biopsy Prostate Using Transrectal or Transperineal Procedure for the Prostate Cancer Diagnostic

Who this might be right for
Patients With Suspected Prostate Cancer
Elsan 101
Early research (Phase 1)Ended earlyNCT01702792
What this trial is testing

Derivation of Tumor Specific Hybridomas

Who this might be right for
Glioblastoma
Dartmouth-Hitchcock Medical Center 1
Testing effectiveness (Phase 2)Study completedNCT01936532
What this trial is testing

Safety and Efficacy Study of a Triplet Combination of MLN9708, Lenalidomide and Dexamethasone in the Initial Management of Multiple Myeloma (IFM2013-06)

Who this might be right for
Newly Diagnosed Multiple Myeloma
Nantes University Hospital 42
Not applicableUnknownNCT00005071
What this trial is testing

Diagnosis and Treatment Planning in Patients Suspected of Having Lung Cancer

Who this might be right for
Lung Cancer
Royal Marsden NHS Foundation Trust
Testing effectiveness (Phase 2)Ended earlyNCT03724253
What this trial is testing

[68Ga]-NeoBOMB1 Imaging in Patients With Malignancies Known to Overexpress Gastrin Releasing Peptide Receptor (GRPR)

Who this might be right for
Breast CancerProstate CancerColorectal Cancer+2 more
Advanced Accelerator Applications 19
Next Page